Literature DB >> 12482472

Operationalizing DSM-IV criteria for PMDD: selecting symptomatic and asymptomatic cycles for research.

Mark J Smith1, Peter J Schmidt, David R Rubinow.   

Abstract

While diagnostic criteria for premenstrual syndromes (PMS) exist, studies rarely state how these criteria are operationally applied. We examined the consequences of application of different operational methods for DSM-IV criteria for premenstrual dysphoric disorder (PMDD) to individual cycles in women with PMS and controls. PMDD criteria require the presence of both certain types or numbers of symptoms (5/11 symptoms present premenstrually, at least one being one of four mood symptoms) and certain phenomenal characteristics (present premenstrually, absent postmenstrually, causing interference premenstrually). We identified individual cycles as symptomatic or asymptomatic by applying criteria that operationalized the required phenomenal elements of PMDD according to four severity thresholds: literal (i.e. present or absent), 30%, 50%, 70%. Data examined were Daily Rating Form symptom scores from two symptomatic menstrual cycles both in 25 women with PMS and 25 controls. Literal thresholds correctly identified 28% of symptomatic and 4% of asymptomatic cycles, compared with 86 and 70% identification with a 30% threshold, 60 and 86% with a 50% threshold, and 0 and 100% with a 70% threshold. An "optimal" combination of 30% thresholds for premenstrual symptomatology and premenstrual interference and a 50% threshold for postmenstrual symptomatology correctly identified 92% of symptomatic cycles in women with PMS and 72% of asymptomatic cycles in controls. Different criteria for cycle inclusion yield markedly different sample compositions. No single operational threshold of the phenomenal features maximizes selection of both symptomatic and asymptomatic cycles, largely consequent to the ubiquity of postmenstrual symptoms and premenstrual "interference" even in women without PMS. At the very least, the method for operationalizing DSM-IV criteria should be described in studies of PMDD.

Entities:  

Mesh:

Year:  2003        PMID: 12482472     DOI: 10.1016/s0022-3956(02)00053-5

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  18 in total

1.  Estrogen receptor alpha (ESR-1) associations with psychological traits in women with PMDD and controls.

Authors:  Alexandra Miller; Hoa Vo; Liang Huo; Catherine Roca; Peter J Schmidt; David R Rubinow
Journal:  J Psychiatr Res       Date:  2010-02-20       Impact factor: 4.791

2.  Sleep and Women's Health.

Authors:  Sara Nowakowski; Jessica Meers; Erin Heimbach
Journal:  Sleep Med Res       Date:  2013

Review 3.  Cognitive Behavioral Therapy for Insomnia and Women's Health: Sex as a Biological Variable.

Authors:  Sara Nowakowski; Jessica M Meers
Journal:  Sleep Med Clin       Date:  2019-03-27

4.  Examination of premenstrual symptoms as a risk factor for depression in postpartum women.

Authors:  Melissa M Buttner; Sarah L Mott; Teri Pearlstein; Scott Stuart; Caron Zlotnick; Michael W O'Hara
Journal:  Arch Womens Ment Health       Date:  2013-01-08       Impact factor: 3.633

5.  The effect of serotonin 1A receptor polymorphism on the cognitive function of premenstrual dysphoric disorder.

Authors:  Ju-Yu Yen; Hung-Pin Tu; Cheng-Sheng Chen; Cheng-Fang Yen; Cheng-Yu Long; Chih-Hung Ko
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-10-26       Impact factor: 5.270

6.  Steroid withdrawal in the mouse results in anxiogenic effects of 3alpha,5beta-THP: a possible model of premenstrual dysphoric disorder.

Authors:  Sheryl S Smith; Yevgeniy Ruderman; Cheryl Frye; Gregg Homanics; Maoli Yuan
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

7.  Predicting response to leuprolide of women with premenstrual dysphoric disorder by daily mood rating dynamics.

Authors:  Steven M Pincus; Shaista Alam; David R Rubinow; Chaya G Bhuvaneswar; Peter J Schmidt
Journal:  J Psychiatr Res       Date:  2010-08-13       Impact factor: 4.791

8.  Toward the Reliable Diagnosis of DSM-5 Premenstrual Dysphoric Disorder: The Carolina Premenstrual Assessment Scoring System (C-PASS).

Authors:  Tory A Eisenlohr-Moul; Susan S Girdler; Katja M Schmalenberger; Danyelle N Dawson; Pallavi Surana; Jacqueline L Johnson; David R Rubinow
Journal:  Am J Psychiatry       Date:  2016-08-13       Impact factor: 18.112

9.  Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene.

Authors:  Liang Huo; Richard E Straub; Catherine Roca; Peter J Schmidt; Kai Shi; Radhakrishna Vakkalanka; Daniel R Weinberger; David R Rubinow
Journal:  Biol Psychiatry       Date:  2007-06-27       Impact factor: 13.382

10.  Facial emotion discrimination across the menstrual cycle in women with premenstrual dysphoric disorder (PMDD) and controls.

Authors:  David R Rubinow; Mark J Smith; Linda A Schenkel; Peter J Schmidt; Kristen Dancer
Journal:  J Affect Disord       Date:  2007-03-26       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.